1
Stanley M Crain, Ke fei Shen, Gerald M Fleischner: Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists. Albert Einstein College of Medicine of Yeshiva University, Amster Rothstein & Ebenstein, February 27, 2001: US06194382 (64 worldwide citation)

This invention relates to a method for eating a subject with irritable bowel syndrome (“IBS”) which comprises long-term administration of an opioid receptor antagonist at an appropriately low dose which will selectively antagonize excitatory opioid receptor functions, but not inhibitory opioid recep ...


2
Stanley M Crain, Ke fei Shen, Gerald M Fleischner: Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists. Albert Einstein College of Medicine of Yeshiva University, Amster Rothstein & Ebenstein, May 28, 2002: US06395705 (61 worldwide citation)

This invention relates to a method for treating a subject with irritable bowel syndrome (“IBS”) which comprises long-term administration of an opioid receptor antagonist at an appropriately low dose which will selectively antagonize excitatory opioid receptor functions, but not inhibitory opioid rec ...


3
Stanley M Crain, Ke fei Shen, Gerald M Fleischner: Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists. Albert Einstein College of Medicine of Yeshiva University, Amster Rothstein & Ebenstein, May 18, 2004: US06737400 (4 worldwide citation)

This invention relates to a method for treating a subject with irritable bowel syndrome (“IBS”) which comprises long-term administration of an opioid receptor antagonist at an appropriately low dose which will selectively antagonize excitatory opioid receptor functions, but not inhibitory opioid rec ...


4
Crain Stanley M, Shen Ke Fei, Fleischner Gerald M: Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists. Einstein Coll Med, November 28, 2001: EP1156792-A1

This invention relates to a method for treating a subject with irritable bowel syndrome ("IBS") which comprises long-term administration of an opioid receptor antagonist at an appropriately low dose which will selectively antagonize excitatory opioid receptor functions, but not inhibitory opioid rec ...


5
Stanley M Crain, Ke fei Shen, Gerald M Fleischner: Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists. Craig J Arnold, Amster Rothstein & Ebenstein, August 30, 2001: US20010018413-A1

This invention relates to a method for treating a subject with irritable bowel syndrome (“IBS”) which comprises long-term administration of an opioid receptor antagonist at an appropriately low dose which will selectively antagonize excitatory opioid receptor functions, but not inhibitory opioid rec ...


6
Stanley M Crain, Ke fei Shen, Gerald M Fleischner: Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists. Amster Rothstein & Ebenstein, May 12, 2005: US20050101622-A1

This invention relates to a method for treating a subject with irritable bowel syndrome (“IBS”) which comprises long-term administration of an opioid receptor antagonist at an appropriately low dose which will selectively antagonize excitatory opioid receptor functions, but not inhibitory opioid rec ...


7
Stanley M Crain, Ke Fei Shen, Gerald M Fleischner: Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists. Craig J Arnold, Amster Rothstein & Ebenstein, November 21, 2002: US20020173466-A1

This invention relates to a method for treating a subject with irritable bowel syndrome (“IBS”) which comprises long-term administration of an opioid receptor antagonist at an appropriately low dose which will selectively antagonize excitatory opioid receptor functions, but not inhibitory opioid rec ...


8
Crain Stanley M, Shen Ke Fei, Fleischner Gerald M: Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists. Albert Einstein College Of Medecine Of Yeshiva University, Crain Stanley M, Shen Ke Fei, Fleischner Gerald M, GEORGE Kenneth P, September 8, 2000: WO/2000/051592

This invention relates to a method for treating a subject with irritable bowel syndrome ('IBS') which comprises long-term administration of an opioid receptor antagonist at an appropriately low dose which will selectively antagonize excitatory opioid receptor functions, but not inhibitory opioid rec ...



Click the thumbnails below to visualize the patent trend.